Los puntos clave no están disponibles para este artículo en este momento.
PSA screening for prostate cancer should involve consideration of benefits and risks. Screening is associated with a small reduction in prostate cancer deaths; risks include overdiagnosis and unnecessary biopsy and treatment.
Pinsky et al. (Wed,) studied this question.